The Food and Drug Administration today recommended medical device manufacturers, health care providers and patients take certain actions to reduce the risk that a remote attacker could exploit a set of cybersecurity vulnerabilities to control a medical device or prevent it from functioning. The agency to date has not received any adverse event reports associated with the vulnerabilities, announced in a July advisory from the Department of Homeland Security. The vulnerabilities exist in IPnet, a third-party software component that supports network communications between computers. The software is part of several operating systems and may be used in a wide range of medical and industrial devices.
 

Headline
The Department of Health and Human Services Aug. 14 released a request for comments through the Office of the National Coordinator for Health IT on a proposed…
Perspective
Public
Every day, hospitals and health systems perform a remarkable balancing act. They invest in talented caregivers, advanced technologies, innovative partnerships…
Headline
U.S. and international agencies released a joint cybersecurity advisory Aug. 10 warning of actions by Gunra ransomware. Gunra is a ransomware-as-a-service…
Headline
The Food and Drug Administration Aug. 3 identified Class I recalls of two convenience kit products. Certain kits by Medline…
Headline
The Food and Drug Administration has identified Class I recalls of two products: certain Astral ventilators by Resmed due to a supercapacitor that may leak…
Headline
The Cybersecurity and Infrastructure Security Agency and other U.S. and international agencies July 29 released joint guidance outlining minimum elements for a…